Abstract
Exogenous nucleotide supplementation during times of rapid growth and stress is preferred because de novo synthesis is insufficient and energetically a costly process. To overcome inefficient utilization of dietary nucleotides due to intestinal cell repulsion and dependency on pH, an efficient controlled delivery system based on chitosan nanoparticles (NPs) was developed. The effects of these (0.2% and 0.4%) RNA-loaded chitosan NPs (Chitosan: RNA ratio 2:1), 0.4% bare RNA, and 0.8% chitosan NPs on productive efficiency (growth rate, feed conversion and protein efficiency ratio), body composition, organo-somatic indices, haemato-biochemical and immune responses (WBC count, phagocytic activity, serum lysozyme, serum total protein and albumin : globulin ratio) and survival of Labeo rohita fish fingerlings, following challenge with pathogenic bacteria were evaluated. Dietary chitosan NPs were found not to affect productive efficiency, but improved (P < 0.01) immunity by increasing WBC and phagocytic activity. Dietary RNA significantly improved (P < 0.01) productive efficiency, immunity and survival, which was further potentiated (P < 0.01) by its nanosized delivery by loading onto chitosan NPs. Blood glucose, haemoglobin, RBC count, serum uric acid and whole body composition were unaffected (P > 0.05) by dietary treatments. RNA-loaded chitosan NPs increased hepato- and viscerosomatic indices. The activity of metabolic enzymes (intestinal and liver alkaline phosphatase, alanine- and aspartateamino transferases, lactate- and malate-dehydrogeneases) corresponded with the performance of the respective diets. As growth, immunity and disease resistance in fish given dietary nano-sized RNA were significantly higher than in those given bare RNA or chitosan alone, and as nanoformulation reduced the usage of individual components by half, the use of RNA-loaded chitosan NPs can be favoured in the feed/food industry over chitosan and RNA alone.
Keywords: Body composition, chitosan nanoparticles, disease resistance, fish, immunity, performance, RNA.
Graphical Abstract
Current Nanoscience
Title:RNA-Loaded Chitosan Nanoparticles for Enhanced Growth, Immunostimulation and Disease Resistance in Fish
Volume: 10 Issue: 3
Author(s): S. Ferosekhan, Subodh Gupta, Arvind R. Singh, Mohd. Ashraf Rather, Rakhi Kumari, Dushyant C. Kothari, Asim Kumar Pal and Sanjay Balkrishna Jadhao
Affiliation:
Keywords: Body composition, chitosan nanoparticles, disease resistance, fish, immunity, performance, RNA.
Abstract: Exogenous nucleotide supplementation during times of rapid growth and stress is preferred because de novo synthesis is insufficient and energetically a costly process. To overcome inefficient utilization of dietary nucleotides due to intestinal cell repulsion and dependency on pH, an efficient controlled delivery system based on chitosan nanoparticles (NPs) was developed. The effects of these (0.2% and 0.4%) RNA-loaded chitosan NPs (Chitosan: RNA ratio 2:1), 0.4% bare RNA, and 0.8% chitosan NPs on productive efficiency (growth rate, feed conversion and protein efficiency ratio), body composition, organo-somatic indices, haemato-biochemical and immune responses (WBC count, phagocytic activity, serum lysozyme, serum total protein and albumin : globulin ratio) and survival of Labeo rohita fish fingerlings, following challenge with pathogenic bacteria were evaluated. Dietary chitosan NPs were found not to affect productive efficiency, but improved (P < 0.01) immunity by increasing WBC and phagocytic activity. Dietary RNA significantly improved (P < 0.01) productive efficiency, immunity and survival, which was further potentiated (P < 0.01) by its nanosized delivery by loading onto chitosan NPs. Blood glucose, haemoglobin, RBC count, serum uric acid and whole body composition were unaffected (P > 0.05) by dietary treatments. RNA-loaded chitosan NPs increased hepato- and viscerosomatic indices. The activity of metabolic enzymes (intestinal and liver alkaline phosphatase, alanine- and aspartateamino transferases, lactate- and malate-dehydrogeneases) corresponded with the performance of the respective diets. As growth, immunity and disease resistance in fish given dietary nano-sized RNA were significantly higher than in those given bare RNA or chitosan alone, and as nanoformulation reduced the usage of individual components by half, the use of RNA-loaded chitosan NPs can be favoured in the feed/food industry over chitosan and RNA alone.
Export Options
About this article
Cite this article as:
Ferosekhan S., Gupta Subodh, Singh R. Arvind, Rather Ashraf Mohd., Kumari Rakhi, Kothari C. Dushyant, Pal Kumar Asim and Jadhao Balkrishna Sanjay, RNA-Loaded Chitosan Nanoparticles for Enhanced Growth, Immunostimulation and Disease Resistance in Fish, Current Nanoscience 2014; 10 (3) . https://dx.doi.org/10.2174/1573413710666140115220300
DOI https://dx.doi.org/10.2174/1573413710666140115220300 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Carotenoids and Cardiovascular Risk
Current Pharmaceutical Design Pharmacokinetic Concepts Revisited - Basic and Applied
Current Pharmaceutical Biotechnology Drug Abuse, Brain Calcification and Glutamate-Induced Neurodegeneration
Current Drug Abuse Reviews Can Probiotics Supplementation Improve Glycemic and Renal Status in Diabetic Nephropathy? A Systematic Review and Meta-Analysis of Clinical Trials
Endocrine, Metabolic & Immune Disorders - Drug Targets SS31, a Small Molecule Antioxidant Peptide, Attenuates β-Amyloid Elevation, Mitochondrial/Synaptic Deterioration and Cognitive Deficit in SAMP8 Mice
Current Alzheimer Research Gabapentin and Pregabalin for the Acute Post-operative Pain Management. A Systematic-narrative Review of the Recent Clinical Evidences
Current Drug Targets Flow and Microwave Assisted Synthesis of Medicinally Relevant Indoles
Current Green Chemistry Elasticity Imaging via MRI: Basics, Overcoming the Waveguide Limit, and Clinical Liver Results
Current Medical Imaging ET-18-OCH3 (Edelfosine): A Selective Antitumour Lipid Targeting Apoptosis Through Intracellular Activation of Fas / CD95 Death Receptor
Current Medicinal Chemistry Aβ Produced as a Fusion to Maltose Binding Protein Can Be Readily Purified and Stably Associates with Copper and Zinc
Protein & Peptide Letters The Development of Cannabinoid CBII Receptor Agonists for the Treatment of Central Neuropathies
Central Nervous System Agents in Medicinal Chemistry GHB – Induced Cognitive Deficits During Adolescence and the Role of NMDA Receptor
Current Neuropharmacology Inflammation, Oxidative Stress and Metabolic Syndrome: Dietary Modulation
Current Vascular Pharmacology Elderly Patients with Migraine: An Open-Label Study on Prophylaxis Therapy with Levetiracetam
Central Nervous System Agents in Medicinal Chemistry Reduction in Ischemic Cerebral Infarction is Mediated through Golgi Phosphoprotein 3 and Akt/mTOR Signaling Following Salvianolate Administration
Current Neurovascular Research Conference Report
CNS & Neurological Disorders - Drug Targets Addictions and Stress: Clues for Cocaine Pharmacotherapies
Current Pharmaceutical Design Cannabinoids: Novel Medicines for the Treatment of Huntingtons Disease
Recent Patents on CNS Drug Discovery (Discontinued) Current Status and Perspectives in Ceramide-Targeting Molecular Medicine
Current Pharmaceutical Design Prenatal Stress and Maternal Immune Dysregulation in Autism Spectrum Disorders: Potential Points for Intervention
Current Pharmaceutical Design